The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

 
Web www.patentalert.com

< 11beta-hydroxysteroid dehydrogenase type 1 active compounds

< Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators

> Methods for treating retinal diseases

> Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
~ 00257